Beta Bionics, Inc. · NASDAQ:BBNX

Hopman Mark sold 775 Beta Bionics, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Hopman Mark (Chief Commercial Officer) sold 775 Beta Bionics, Inc. shares at US$16.22 for US$12,571 under a trading plan, leaving 54,143 shares. Filed Nov 18, 2026 (Form 4).

Sold
775 shares
Price
US$16.22
Value
US$12,571
Holding after
54,143 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockOption exercise775US$5.1054,918Direct
Nov 16, 2026Common StockSale775US$16.2254,143Direct

Source

Download original · View original at SEC

Related